N-Ethyl-2C-B is a recreational designer drug with psychedelic effects.[1] It was first synthesised in the 1990s,[2] and was first identified as a new psychoactive substance in Finland in 2007.[3] It is specifically listed as an illegal drug in Finland,[4] and controlled under analogue provisions in a number of other jurisdictions.

N-Ethyl-2C-B
Legal status
Legal status
  • UK: In General Unscheduled
Identifiers
  • 2-(4-bromo-2,5-dimethoxyphenyl)-N-ethylethanamine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H18BrNO2
Molar mass288.185 g·mol−1
3D model (JSmol)
  • COC1=CC(CCNCC)=C(OC)C=C1Br
  • InChI=1S/C12H18BrNO2/c1-4-14-6-5-9-7-12(16-3)10(13)8-11(9)15-2/h7-8,14H,4-6H2,1-3H3
  • Key:FTXAZQUDSNEXMB-UHFFFAOYSA-N

See also

edit

References

edit
  1. ^ Schifano F, Orsolini L, Papanti D, Corkery J (2017). "NPS: Medical Consequences Associated with Their Intake". Neuropharmacology of New Psychoactive Substances (NPS). Current Topics in Behavioral Neurosciences. Vol. 32. pp. 351–380. doi:10.1007/7854_2016_15. ISBN 978-3-319-52442-9. PMID 27272067.
  2. ^ Glennon RA, Dukat M, el-Bermawy M, Law H, De los Angeles J, Teitler M, King A, Herrick-Davis K (June 1994). "Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines". Journal of Medicinal Chemistry. 37 (13): 1929–35. doi:10.1021/jm00039a004. PMID 8027974.
  3. ^ "2007 Annual Report on the implementation of Council Decision 2005/387/JHA" (PDF). European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) & Europol.
  4. ^ "Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista" [Government Decree on Psychoactive Substances Banned from the Consumer Market]. Finlex Data Bank (in Finnish).